Media Center

Astex in the News

Cambridge A-listers Astex and AstraZeneca toast progress of another cancer drug prospect

January, Business Weekly (page 23) – read more

Interview with Harren Jhoti: How Astex built a business based on fragment-based drug discovery

Nov – Dec, MedNous – Issue 2023 – read more

Third Success from Astex Drug Discovery Pharma Collaborations as AstraZeneca Receives US Marketing Approval for Cancer Drug Truqap (capivasertib).

November 17, 2023 – read more

Dr Harren Jhoti FRS OBE wins Business Person of the Year at the 21st annual Asian Achievers Awards

September 15, 2023 – read more

Astex bags another cancer deal with MSD, this time for “undruggable” p53 target

August 9, 2023 – read more

UK’s Astex adds onto Merck partnership via $35M upfront for tumor suppressor protein candidates

August 8, 2023 – read more

Merck enlists Astex to search for p53 cancer drug in expanded deal

August 8, 2023 – read more

Astex hails trials success of superdrug that saves lives and cuts recurrence risk for thousands of breast cancer patients

June 7, 2023 – read more

Breast cancer drug cuts risk of most common form returning by 25%

June 2, 2023 – read more

Astex wins Life Science Company of the Year at the Cambridge Independent Science and Technology Awards 2023

May 18, 2023 – read more

Astex is a finalist for the Cambridge Independent Science and Technology Awards 2023

March 15, 2023 – read more

Astex and Cardiff University Medicines Discovery Institute to Collaborate on neurodegenerative diseases

February 14, 2023 – read more

Cardiff University and Astex in drug discovery collaboration

February 13, 2023 – read more

Astex and Cardiff University seek new drugs to treat neurodegenerative diseases

February 13, 2023 – read more

Fit for a king! Astex chief made OBE in historic honours list

January 3, 2023 – read more

Astex Co-founder and CEO Harren Jhoti Awarded OBE in the King’s New Year Honours

January 1, 2023 – read more

Astex and AstraZeneca deliver ‘landmark’ breast cancer drug

December 15, 2022 – read more

Cambridge on the cusp of its third blockbuster drug coup

December 13, 2022 – read more

New targeted drug shows benefit against breast cancer in first phase III trial

December 9, 2022 – read more

New targeted drug shows benefit against breast cancer in first phase III trial

December 8, 2022 – read more

Cryo-EM Incites a “Resolution Revolution,” Rousing Drug Discovery article – Includes interview with Astex’s Senior Director (Molecular Sciences) Dr. Pamela Williams featured in the Cryo-EM meets fragment-based drug design section

December 7, 2022 – read more

Cancer Research UK and Newcastle University announce alliance extension with Astex Pharmaceuticals (UK)

November 22, 2022 – read more

Capivasertib plus Faslodex significantly improved progression-free survival vs. Faslodex in CAPItello-291 Phase III trial in advanced HR-positive breast cancer

October 26, 2022 – read more

Astex wins 3 awards for participating in The BioIndustry Association (BIA) 850 Global Challenge for Kidney Research UK 2022

May 30, 2022 – read more

Astex enters new partnership with the UK Dementia Research Institute to accelerate progress in dementia research

April 6, 2022 – read more

David Rees, Chief Scientific Officer, joins The Rosalind Franklin Institute (RFI) Board of Directors

September 1, 2021 – read more

Astex scientist, Pamela Williams, wins the Biochemical Society’s Industry and Academic Collaboration Award

September, 2021 – read more

Taiho and Astex Extend Strategic Oncology Collaboration with MSD Granting Exclusive License to SHP2 Program

January 13, 2021 – read more

David Rees, Chief Scientific Officer, inducted to the Royal Society of Chemistry BMCS (Biological and Medicinal Chemistry Sector) Hall of Fame

December 1, 2020 – read more

Astex’s VP Intellectual Property, Michelle Jones, is named as one of the Managing IP Corporate IP Stars of 2020

July 28, 2020 – read more

Astex CSO, David Rees, elected as new Fellow of the Academy of Medical Sciences

May 13, 2020 – read more

Merck Establishes Strategic Oncology Collaboration with Taiho and Astex (KRAS programme)

January 6, 2020 – read more

An Entrepreneurs Journey Part II: Harren Jhoti, President and CEO Astex Pharmaceuticals

Nov 25, 2019 – Read more

An Entrepreneurs Journey Part I: Harren Jhoti, President and CEO Astex Pharmaceuticals text

Nov 22, 2019 – Read more

Astex is featured in Biology Impacting Lives, an ITN Productions programme created in partnership with the Royal Society of Biology

April 15, 2019 – view video

https://astx.com/wp-admin/post.php?post=1618&action=edit&classic-editor=1#save

Astex targets CNS with fragment-based approach

November 1, 2016 – read more

Astex scientist, Alison Woolford, wins Capps Green Zomaya Award

April 15, 2016 – read more

Open Innovation: The Answer To Slow Pharmaceutical Productivity

September 1, 2015 – read more